menu search

Beam therapeutics stock: bear vs. bull

Pre-revenue biotechs like beam Therapeutics bring plenty of risk. The good news is that it has plenty o...

October 21, 2023, 8:45 am

Beam focuses on developing gene drug for growth

While beam's pipeline candidates are in early-stage clinical studies, their development is progressing ...

October 10, 2023, 11:16 am

Beam global (beem) q2 2023 earnings call transcript

Beam Global (NASDAQ:BEEM ) Q2 2023 Earnings Conference Call August 14, 2023 4:20 AM ET Company Participants Kathy McDermott - Chief Financial Officer ...

August 14, 2023, 10:37 pm

Meitnerium market revenue to cross us$ 92.9 thousand, globally by 2031 – comprehensive study by transparency market research

Rise in demand for particle beam radiation therapies for cancer is expected to accelerate meitnerium ma...

June 24, 2023, 8:00 am

Beam global executes binding loi to acquire europe based amiga, announces pricing of upsized $22.5 million public offering of common stock and announces q2 revenue and unit guidance

The planned accretive transaction is intended to expand Beam Global’s business into the European market and increas...

June 20, 2023, 1:40 am

Beam global executes binding loi to acquire europe based amiga, announces proposed public offering of common stock and announces q2 revenue and unit guidance

The planned accretive transaction is intended to expand Beam Global’s business into the European market and increas...

June 16, 2023, 9:50 pm

Beam global (beem) q1 2023 earnings call transcript

Beam Global (NASDAQ:BEEM ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Kathy McDermott - Chief Financial Officer Des...

May 15, 2023, 11:25 pm

Beam global (beem) q4 2022 earnings call transcript

Beam Global (NASDAQ:BEEM ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Kathy McDermott - Chief Financial Officer D...

March 30, 2023, 12:37 am

Beam global (beem) q3 2022 results - earnings call transcript

Beam Global (NASDAQ:BEEM ) Q3 2022 Results Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Desmond Wheatley - President, Ch...

November 10, 2022, 11:50 pm

Revisiting beam therapeutics among collaborative catalysts

The recent 4-year partnership between Pfizer and Beam Therapeutics involves $300 million upfront to speed validation of the technology and an addition...

July 10, 2022, 10:06 am


Search within

Pages Search Results: